These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1716794)

  • 21. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    Lippman W; Pugsley TA
    Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxicity of chlorpromazine and modulation by amantadine as a function of mouse strain.
    Messiha FS
    Neurotoxicology; 1991; 12(3):571-81. PubMed ID: 1745440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effects of aspartame on concentrations of brain amines and their metabolites in selected brain regions of Fischer 344 and Sprague-Dawley rats.
    Freeman G; Sobotka T; Hattan D
    Drug Chem Toxicol; 1990; 13(2-3):113-33. PubMed ID: 1703475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential modulation of mouse brain biogenic amines by haloperidol and pimozide: implications in Tourette's syndrome.
    Messiha FS
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 97(1):43-7. PubMed ID: 1981344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serotonin and dopamine brain metabolism in mice with different predisposition to catalepsy].
    Sinyakova NA; Kulikova EA; Kulikov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(6):686-92. PubMed ID: 25975144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain.
    Soininen H; Unni L; Shillcutt S
    Neurochem Res; 1990 Dec; 15(12):1185-90. PubMed ID: 1711162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of various tricyclic antidepressants on amine uptake.
    Ishikawa K; Shibanoki S; Kubo T; Watabe S; Matsumoto A; Kogure M
    Eur J Pharmacol; 1986 Jan; 120(1):63-8. PubMed ID: 2936613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VD; Konstantinova E
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperidine: effects on locomotor activity and brain monoamine turnover.
    Alm B
    Psychopharmacology (Berl); 1976 Nov; 50(3):301-4. PubMed ID: 826977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions.
    Slotkin TA; Seidler FJ; Ali SF
    Brain Res; 2000 Oct; 879(1-2):163-73. PubMed ID: 11011018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
    Dunn AJ; Berridge CW
    Pharmacol Biochem Behav; 1987 Aug; 27(4):685-91. PubMed ID: 2443934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of progesterone on serotonin turnover in rats primed with estrogen implants into the ventromedial hypothalamus.
    Gereau RW; Kedzie KA; Renner KJ
    Brain Res Bull; 1993; 32(3):293-300. PubMed ID: 7690679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus.
    Sloot WN; van der Sluijs-Gelling AJ; Gramsbergen JB
    J Neurochem; 1994 Jan; 62(1):205-16. PubMed ID: 7505311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in rat brain monoamine turnover following chronic antidepressant administration.
    Sugrue MF
    Life Sci; 1980 Feb; 26(6):423-9. PubMed ID: 6154860
    [No Abstract]   [Full Text] [Related]  

  • 39. Contents of monoamines in forebrain regions of alcohol-preferring (P) and -nonpreferring (NP) lines of rats.
    Murphy JM; McBride WJ; Lumeng L; Li TK
    Pharmacol Biochem Behav; 1987 Feb; 26(2):389-92. PubMed ID: 2437596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of mitigation of methamphetamine-induced neurotoxicity by ganglioside GM1 or vitamin E.
    Ali SF
    Ann N Y Acad Sci; 1995 Sep; 765():311. PubMed ID: 7486624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.